INmune Bio and Quantum Computing Inc. partner on quantum optimization and AI for Alzheimer’s drug research
INmune Bio will combine its clinical research with QCi's Dirac-3S quantum optimization machine to look for new treatment indications and biomarkers for its drug XPro. The deal is QCi's first commercial customer in pharmaceuticals and biotech.